The FDA noted that Veronvy, a company that claims its products assist in weight loss and metabolism-boosting, said people on one of its products not only lost weight but also kept it off. In addition to a reduced-calorie diet and increased physical activity, Veronvy said its metabolic boost drops successfully helped people lose up to 52 pounds in three months during clinical trials and was approved by the Food and Drug Administration last year. The FDA said Veronvys products are intended to prevent, treat, or cure disease conditions and/or affect the structure or function of the body and categorized these supplements as unapproved drugs
The FDA has announced the issuance of 30 warning letters to telehealth companies, targeting firms making false or misleading claims regarding compounded GLP-1 products, such as semaglutide and tirzepatide, offered on their digital platforms
Do you think GLP-1 agonists are a good choice for me
In a SAXENDA clinical trial in adult patients with overweight (excess weight) or obesity with type 2 diabetes mellitus treated with basal insulin and SAXENDA in combination with a reduced-calorie diet and increased physical activity and up to 2 oral anti-diabetes medications, severe hypoglycemia was reported by 3 (1.5%) of 195 SAXENDA-treated patients and 2 (1%) of 197 placebo-treated patients
To keep it light: Start with a small scoop of yogurt Add a few berries or seeds Mix in a scoop of protein powder if you want more protein without more food These bowls often feel closer to dessert than a meal
It is not approved for human or veterinary use, not intended for diagnostic or therapeutic purposes, and should not be administered to humans or animals under any circumstances
